Home
OrbiMed Israel GP II, 10% Owner: Damora Therapeutics DMRA Sell · Filed 23/08/17
Trade details
- Type
- Insider sale
- Amount
- $401,650.5
- Shares · price
- 535,534 sh · $0.75 a share
- Held after
- 1,510,375 sh
- Trade date
- 23/08/15
- Filed
- 23/08/17
- Days to filing
- 2 days
Sold 26.2% of holdings
- Share of holding sold
- 26.2%
Damora Therapeutics trades, last 26 weeks
What else happened in Damora Therapeutics around then
Filed or reported within 30 days of the trade day · 23/07/16~23/09/14OrbiMed Israel GP II's recent trades
- OrbiMed Israel GP II
BuyADARx Pharmaceuticals
BuyADARx Pharmaceuticals
ADRX
$10M
588,235 sh
$10M
Filed 09/30
Traded 09/28
- OrbiMed Israel GP II
BuyADARx Pharmaceuticals
BuyADARx Pharmaceuticals
ADRX
$5.1M
300,249 sh
$5.1M
Filed 09/30
Traded 09/28
- OrbiMed Israel GP II
BuyADARx Pharmaceuticals
BuyADARx Pharmaceuticals
ADRX
$1M
61,516 sh
$1M
Filed 09/30
Traded 09/28
- OrbiMed Israel GP II
SellAdicet Bio
SellAdicet Bio
ACET
$263.5K
40,416 sh
$263.5K
Filed 04/09
Traded 04/08
- OrbiMed Israel GP II
SellAdicet Bio
SellAdicet Bio
ACET
$204.6K
32,523 sh
$204.6K
Filed 04/09
Traded 04/08